The elderly are a rapidly growing segment of the population with a high likelihood of acute coronary disease and worse outcomes after acute coronary syndromes than younger groups. Although underrepresented in clinical trial populations, they benefit to an equal or greater extent from treatment with proven medications and interventions, and survivors to hospital discharge have excellent longer term functional outcomes. With consideration of individual preferences for treatment and inherent risks for side-effects in this population, age alone should not determine management of elderly acute coronary syndrome patients. J Cardiovasc Med 12:220-222 (C) 2011 Italian Federation of Cardiology.
机构:
Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain
Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain
Cardiovasc Res Chair UAB, Barcelona, SpainCardiovasc Res Ctr CSIC ICCC, Barcelona, Spain
机构:
Bellvitge Univ Hosp, Internal Med Dept, Geriatr Med Unit, Barcelona, SpainBellvitge Univ Hosp, Internal Med Dept, Geriatr Med Unit, Barcelona, Spain
Formiga, Francesc
Ariza-Sole, Albert
论文数: 0引用数: 0
h-index: 0
机构:
Bellvitge Univ Hosp, Dept Cardiol, Barcelona, SpainBellvitge Univ Hosp, Internal Med Dept, Geriatr Med Unit, Barcelona, Spain